Top Page
BXP
(NYSE:BXP)
BXP (BXP) vs. SPDR S&P 500 ETF (SPY)
BXP Business Overview & Revenue Model
BXP Earnings Call Summary
BXP Financial Statement Overview
| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 3.48B | 3.41B | 3.27B | 3.11B | 2.89B |
| Gross Profit | 2.11B | 2.09B | 2.06B | 1.97B | 1.85B |
| EBITDA | 1.94B | 1.62B | 1.70B | 2.21B | 1.78B |
| Net Income | 276.80M | 14.27M | 190.22M | 848.95M | 505.19M |
Balance Sheet | |||||
| Total Assets | 26.17B | 26.08B | 26.03B | 24.21B | 22.37B |
| Cash, Cash Equivalents and Short-Term Investments | 1.48B | 1.25B | 1.53B | 690.33M | 452.69M |
| Total Debt | 17.36B | 17.32B | 16.62B | 14.69B | 13.35B |
| Total Liabilities | 18.48B | 18.14B | 17.83B | 15.84B | 14.32B |
| Stockholders Equity | 5.15B | 5.41B | 5.89B | 6.13B | 5.84B |
Cash Flow | |||||
| Free Cash Flow | 689.66M | 786.52M | 819.17M | 884.31M | 1.12B |
| Operating Cash Flow | 1.25B | 1.23B | 1.30B | 1.28B | 1.13B |
| Investing Cash Flow | -603.86M | -1.24B | -1.19B | -1.60B | -1.04B |
| Financing Cash Flow | -419.23M | -274.48M | 767.92M | 556.06M | -1.31B |
BXP Technical Analysis
BXP Risk Analysis
BXP Peers Comparison
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
65 Neutral | $2.17B | 12.19 | 3.79% | 4.94% | 3.15% | 1.96% | |
60 Neutral | $8.98B | -5.83 | -8.62% | 10.90% | -0.76% | -250.60% | |
57 Neutral | $3.70B | 89.50 | 5.09% | 5.75% | 0.77% | 62.58% | |
55 Neutral | $5.87B | 7.05 | 16.24% | 2.24% | 2.41% | ― | |
53 Neutral | $3.99B | 106.88 | 0.85% | 5.08% | 16.38% | 3.60% | |
51 Neutral | $3.02B | -36.60 | -2.25% | 6.95% | 8.60% | ― | |
50 Neutral | $9.66B | 38.78 | 5.24% | 5.26% | 2.54% | -155.17% |
BXP Corporate Events
On March 6, 2026, BXP, Inc. and its operating partnership filed new automatic shelf registration statements with the SEC to replace expiring shelves, including one covering its Dividend Reinvestment and Stock Purchase Plan. The company simultaneously filed prospectus supplements for a new $1.0 billion at-the-market equity program, the potential issuance of up to 152,905 common shares upon redemption of partnership units, and the resale of up to 13,252,000 shares issuable upon exchange of its 2.00% Exchangeable Senior Notes due 2030.
Under the three-year at-the-market program, BXP may issue up to $1.0 billion of common stock from time to time, including through forward sale arrangements with a syndicate of banks and broker-dealers acting as sales agents, forward sellers and forward purchasers. The structure provides BXP with flexible access to equity capital, including the ability to hedge and later settle forward sales in shares or cash, while aligning issuance timing and size with market conditions, trading prices and its evolving capital needs, with transaction commissions capped at 2.0% of gross sales or hedging activity.
The most recent analyst rating on (BXP) stock is a Hold with a $56.00 price target. To see the full list of analyst forecasts on BXP stock, see the BXP Stock Forecast page.
On March 6, 2026, BXP, Inc. and its operating partnership filed new automatic shelf registration statements with the SEC to replace expiring ones, including a universal shelf and a separate shelf tied to its Dividend Reinvestment and Stock Purchase Plan. In conjunction with these filings, BXP also introduced new prospectus supplements covering up to 152,905 shares issuable upon redemption of partnership units and up to 13,252,000 shares tied to its 2.00% Exchangeable Senior Notes due 2030.
The company simultaneously launched a new three-year, $1.0 billion at-the-market equity offering program, replacing a prior $600 million program that is no longer effective. Under a broad sales agency and forward sale framework with multiple major banks, BXP can sell common shares directly or via complex forward sale agreements, providing flexible access to equity capital that can be timed to market conditions and capital needs while setting sales agent and forward seller compensation at up to 2% of gross sale prices.
The Sales Agreement allows BXP to execute sales on the NYSE, through market makers, electronic networks, or negotiated and block transactions, with the company and agents retaining the ability to suspend or terminate sales at any time. This capital markets platform, together with the refreshed shelf registrations, strengthens BXP’s ability to raise equity efficiently over the next three years, supporting its funding strategy without obligating it to issue shares unless conditions are attractive.
The most recent analyst rating on (BXP) stock is a Hold with a $56.00 price target. To see the full list of analyst forecasts on BXP stock, see the BXP Stock Forecast page.
On December 22, 2025, BXP extended and amended the employment agreement of Chief Executive Officer and Chairman Owen D. Thomas, committing him to remain in the role through December 31, 2029, a move designed to ensure leadership continuity and align his tenure with the company’s multi-year strategic action plan introduced in September 2025; the agreement preserves his existing compensation structure while formalizing retirement-related equity treatment and maintaining robust change-in-control and non-compete provisions. On the same date, the board approved a 2025 Outperformance Plan that grants up to 711,864 performance-based LTIP units to Thomas and other senior executives, with vesting tied to both service and ambitious stock price and dividend-adjusted performance thresholds—requiring at least a roughly 30% share price increase before any payout and up to about a 70% gain for maximum awards—intended to tightly link executive pay to shareholder returns; BXP expects to recognize about $32.1 million of related compensation expense over the four-year performance period, including roughly $11.6 million in 2026, a modest earnings headwind that signals a stronger emphasis on performance-driven, shareholder-aligned incentives for top management.
The most recent analyst rating on (BXP) stock is a Buy with a $79.00 price target. To see the full list of analyst forecasts on BXP stock, see the BXP Stock Forecast page.
On December 22, 2025, BXP extended the employment agreement of Chief Executive Officer and Chairman Owen D. Thomas by three years to December 31, 2029, largely preserving his existing compensation structure while reinforcing his role in executing the company’s multi-year strategic action plan. The new agreement clarifies severance, retirement eligibility and non-compete terms, and explicitly ties Thomas’s continued service to the value-creation horizon of the plan, signaling the board’s emphasis on leadership continuity and long-term strategy execution. On the same date, BXP’s board approved a 2025 Outperformance Plan that grants up to 711,864 performance-based LTIP units to Thomas and other senior executives, payable only if dividend-adjusted share price gains reach at least 30% and up to about 70% over a four-year performance period ending December 22, 2029, with strict service-based vesting and no retirement-related acceleration. The company expects to recognize approximately $32.1 million of compensation expense from these awards over the four-year period, including about $11.6 million, or $0.07 per share, in 2026, highlighting a deliberate shift to performance-linked equity that tightens alignment between management pay and shareholder returns while modestly increasing reported compensation costs over the life of the plan.
The most recent analyst rating on (BXP) stock is a Buy with a $79.00 price target. To see the full list of analyst forecasts on BXP stock, see the BXP Stock Forecast page.